Back
Cytokinetics Vs. BioNTech SE Industry Stock Comparison
Buy
53
CYTK
Cytokinetics
Last Price:
55.63
Seasonality Move:
-7.7%
Sell
49
BNTX
BioNTech SE
Last Price:
112.39
Seasonality Move:
12.7%
Buy
53
Cytokinetics (CYTK)
is a Buy
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $55.64. The Score for CYTK is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
BioNTech SE (BNTX)
is a Sell
Is BioNTech SE a Buy, Sell or Hold?
- The current BioNTech SE [BNTX] share price is $112.51. The Score for BNTX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- BNTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $55.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
BNTX Stock Price Chart
What is BioNTech SE's stock price today?
-
The BioNTech SE share price today is $112.51
The current trend is moderately bullish and BNTX is experiencing slight selling pressure.
CYTK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 49.64 | Sell |
| Chaikin Money Flow: | 1310466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.83 - 56.97) | Sell |
| Bollinger Bands (100): | (52.24 - 59.92) | Sell |
BNTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.5 | Buy |
| Relative Strength Index (14 RSI): | 65.41 | Buy |
| Chaikin Money Flow: | -684853 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.83 - 109.47) | Buy |
| Bollinger Bands (100): | (81.16 - 100) | Buy |
CYTK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.29 | Buy |
| 20-day SMA: | 55.71 | Sell |
| 50-day SMA: | 56.24 | Sell |
| 200-day SMA: | 62.81 | Sell |
| 8-day EMA: | 55.64 | Buy |
| 20-day EMA: | 55.66 | Sell |
| 50-day EMA: | 56.02 | Sell |
| 200-day EMA: | 56.45 | Sell |
BNTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 113.1 | Sell |
| 20-day SMA: | 98.82 | Buy |
| 50-day SMA: | 90.18 | Buy |
| 200-day SMA: | 93.15 | Buy |
| 8-day EMA: | 112.32 | Buy |
| 20-day EMA: | 102.78 | Buy |
| 50-day EMA: | 94.47 | Buy |
| 200-day EMA: | 94.88 | Buy |
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.09 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.
BioNTech SE Earnings Growth & BNTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.72 per share, an increase next quarter of $0.10 per share, a decrease this year of $7.38 per share, and a decrease next year of $0.37 per share.
Cytokinetics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BioNTech SE Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||